11/20 Yahoo! Finance: PFE News

Please add updates@feedmyinbox.com to your address book to make sure you receive these messages in the future. Yahoo! Finance: PFE News - Latest Financial News for PFIZER INC 'Fast Money' Recap: Playing Defense (at TheStreet.com) November 19, 2009 at 7:46 pm UPDATE - US panel backs new claim for Pfizer lung drug (at Reuters) November 19, 2009 at 5:42 pm InPlay: Pfizer: FDA advisory committee finds data support the claim that SPIRIVA handiHaler reduces COPD exacerbations (Briefing.com) November 19, 2009 at 4:36 pm FDA Advisory Committee Finds Data Support the Claim That SPIRIVA® HandiHaler® Reduces COPD Exacerbations (Business Wire) November 19, 2009 at 4:36 pm RIDGEFIELD, Conn. & NEW YORK----The U.S. Food and Drug Administration Pulmonary-Allergy Drugs Advisory Committee voted 11 to 1 that clinical data included in a supplemental new drug application provide substantial and convincing evidence to support the claim that SPIRIVA® HandiHaler® reduces exacerbations in patients with chronic obstructive pulmonary disease . Pfizer Dodges a Bullet (at Motley Fool) November 19, 2009 at 4:19 pm Health Fraud Caseload Grows at Justice Department (at The Wall Street Journal Online) November 19, 2009 at 3:51 pm FDA panel backs safety, benefits of Spiriva (AP) November 19, 2009 at 3:45 pm Federal health experts on Thursday brushed off lingering safety questions about a popular inhaler drug and suggested it carry bolder benefit claims. UPDATE - US panel backs new claim for Pfizer lung drug (at Reuters) November 19, 2009 at 3:34 pm The Only Way to Earn 50% Annual Returns (at Motley Fool) November 19, 2009 at 3:19 pm Pfizer's Generic Growth, With a Side of Sashimi (at Motley Fool) November 19, 2009 at 3:10 pm Big Pharma Under Pressure as Drug Patents Expire and Pipeline Slows (at Seeking Alpha) November 19, 2009 at 3:03 pm Moody's gives negative view on pharma credit (AP) November 19, 2009 at 1:30 pm Moody's Investors Service issued a negative opinion on the pharmaceutical industry Thursday, saying drugmaker credit ratings will be under pressure until early 2012 because they won't be able to fully replace revenue from best-sellers that go off-patent. UPDATE - Healthcare stocks not unduly hurt by Senate plan (at Reuters) November 19, 2009 at 12:54 pm Why Pfizer Wants You to Take Your Dog Home for Thanksgiving (at The Wall Street Journal Online) November 19, 2009 at 10:39 am Panel Backing for Prevnar 13 (Zacks.com) November 19, 2009 at 10:09 am EU to seek details of drugmakers' patent deals (at Reuters) November 19, 2009 at 9:28 am Pfizer Encourages Families To Bring Their Dogs To This Year's Holiday Celebration (Business Wire) November 19, 2009 at 9:00 am NEW YORK----Pfizer Animal Health wants families to talk with one another about bringing the family dog along when they travel to their Thanksgiving-to-New Year’s celebrations. [$$] Overbought, With Negative Divergences (at RealMoney by TheStreet.com) November 19, 2009 at 7:05 am Pfizer to Begin Selling Generics in Japan (at TheStreet.com) November 19, 2009 at 12:39 am UPDATE - U.S. Democrats demand analysis of drug price rises (at Reuters) November 19, 2009 at 12:01 am Winners, losers in U.S. Senate health bill (at Reuters) November 18, 2009 at 11:29 pm UPDATE - Pfizer says may enter Japan generic drug market (at Reuters) November 18, 2009 at 10:53 pm   This email was sent to gatdemit001@gmail.com.  Create Your Account Don't want to receive this feed any longer? Unsubscribe here.